MedTrace Logo

Study of Treatment for Opioid Dependence and Anxiety Disorders

NCT02252068 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2020-11-17

Study results available
· View outcomes & findings →

Summary

Anxiety is highly prevalent among individuals with opioid dependence and confers greater risk for continued opioid use and poor treatment outcomes. However, there are currently no efficacious treatments available for co-occurring opioid dependence and anxiety. The ultimate aims of this trial are the development and testing of a novel integrated cognitive behavioral treatment (I-CBT) for co-occurring opioid dependence and anxiety disorders. This clinical trial consists of two phases: (1) open-trial pilot (2) randomized control trial. We hypothesize that I-CBT will be a feasible and acceptable treatment that will result in significant reductions in anxiety and opioid use.

Conditions

  • Anxiety Disorders
  • Opiate Addiction

Interventions

BEHAVIORAL

I-CBT

New cognitive behavioral therapy treatment manual developed to treat co-occurring anxiety and opioid dependency disorders.

BEHAVIORAL

IDC

Individual Drug Counseling manual that has demonstrated efficacy for the treatment of drug dependence.

Sponsors & Collaborators

  • Mclean Hospital

    lead OTHER

Principal Investigators

  • Rebecca K McHugh, PhD · Mclean Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2019-10-24
Completion
2019-12-19

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02252068 on ClinicalTrials.gov